| |
Mean scores ± SD of women FGM/C
|
Mean scores ± SD of women without FGM/C
|
|---|
|
All (n = 124)
|
I (n = 9)
|
II (n = 41)
|
III (n = 74)
|
Without PFD9
|
With PFD9
|
|---|
|
Dutch
|
Africaans
|
Sesotho
|
Dutch
|
Africaans
|
Sesotho
|
|---|
|
Age
|
31.5 ± 7.5
| | | |
47.0 ± 15.3
|
48.8 ± 13.4
|
46.5 ± 11.8
|
58.6 ± 12.2
|
59.9 ± 9.8
|
56.4 ± 11.8
|
|
Parity
|
1.3 ± 1.4
| | | |
NA
|
3 (1–5)
|
3 (1–7)
|
2.3 ± 1.2
|
3 (0–6)
|
4 (0–8)
|
|
PFDI-201
|
49.5 ± 52.0
|
33.8 ± 33.1
|
45.5 ± 45.4
|
53.7 ± 57.0
|
27.1 ± 31.7
|
16.1 ± 22.3
|
27.1 ± 31.7
|
93.4 ± 41.5
|
131.8 ± 59.2
|
124.9 ± 55.2
|
|
UDI-62
|
19.6 ± 23.5
|
14.8 ± 22.0
|
17.5 ± 20.3
|
21.3 ± 25.3
|
12.3 ± 16.1
|
4.8 ± 6.9
|
12.3 ± 16.1
|
44.7 ± 20.7
|
45.2 ± 27.8
|
26.0 ± 24.9
|
|
POPDI-63
|
12.2 ± 18.8
|
5.5 ± 9.3
|
11.0 ± 17.1
|
13.7 ± 20.4
|
5.6 ± 9.8
|
6.8 ± 12.7
|
5.6 ± 9.8
|
22.2 ± 16.5
|
52.1 ± 23.2
|
54.7 ± 21.8
|
|
CRADI-84
|
17.8 ± 18.9
|
14.6 ± 16.8
|
17.0 ± 19.1
|
18.6 ± 19.3
|
9.3 ± 12.4
|
4.4 ± 6.9
|
9.3 ± 12.4
|
26.7 ± 19.5
|
32.2 ± 25.2
|
31.7 ± 21.8
|
|
PFIQ-75
|
40.7 ± 53.6
|
29.1 ± 51.9
|
32.6 ± 48.1
|
46.6 ± 56.5
|
12.7 ± 27.0
|
13.2 ± 15.1
|
12.7 ± 27.0
|
69.0 ± 52.5
|
115.5 ± 61.6
|
116.1 ± 62.4
|
|
UIQ-76
|
8.7 ± 18.4
|
5.3 ± 15.9
|
7.0 ± 18.7
|
10.0 ± 18.6
|
5.0 ± 11.3
|
4.7 ± 5.8
|
5.0 ± 11.3
|
35.1 ± 26.3
|
44.2 ± 29.1
|
39.8 ± 27.8
|
|
POPIQ-77
|
16.6 ± 29.4
|
13.9 ± 33.2
|
11.3 ± 20.7
|
20.0 ± 32.7
|
3.4 ± 10.0
|
5.1 ± 7.9
|
3.4 ± 10.0
|
14.6 ± 22.4
|
45.4 ± 27.0
|
46.1 ± 25.6
|
|
CRAIQ-78
|
8.7 ± 19.7
|
9.5 ± 20.2
|
7.3 ± 18.4
|
9.4 ± 20.6
|
4.3 ± 11.9
|
2.9 ± 4.9
|
4.3 ± 11.9
|
20.9 ± 27.2
|
25.9 ± 26.2
|
30.2 ± 26.5
|
- 1Pelvic Floor Distress Inventory
- 2Urinary Distress Inventory
- 3Pelvic Organ Prolapse Distress Inventory
- 4ColoRectal-Anal Distress Inventory
- 5Pelvic Floor Impact Questionnaire
- 6Urinary Impact Questionnaire
- 7Pelvic Organ Prolapse Impact Questionnaire
- 8ColoRectal-Anal Impact Questionnaire
- 9Pelvic floor dysfunction (urinary incontinence and/or pelvic organ prolapse and/or fecal incontinence)
